InMed Pharmaceuticals Inc. (INM) Reports Q1 Loss of $2.17
Tweet
Share
E-mailGet Alerts INM Hot Sheet
Join SI Premium – FREE
InMed Pharmaceuticals Inc. (NASDAQ: INM) reported Q1 EPS of ($2.17). Revenue for the quarter came in at $1.26 million.
For earnings history and earnings-related data on InMed Pharmaceuticals Inc. (INM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BRP Inc. (DOO) Reports Q2 Loss of Cd$0.18
- ZenaTech completes initial prototype of IQ Octo agriculture drone
- Duluth Holdings Inc. (DLTH) Tops Q2 EPS by 49c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
